Search papers, labs, and topics across Lattice.
This study evaluates the effectiveness of open-weights Large Language Models (LLMs) in assessing dementia and depression severity from speech samples during clinical interviews with 154 German-speaking subjects. By introducing a new observer-based Global Depression Scale (GDS-D) aligned with the Global Deterioration Scale (GDS), the research enables a dual assessment of cognitive and affective symptoms. The findings reveal that while LLMs can predict depression severity effectively in zero-shot settings, structured feature extraction significantly enhances dementia assessment accuracy, reducing errors by up to 35% compared to zero-shot approaches.
LLMs can achieve a 35% reduction in dementia assessment errors through structured feature extraction, highlighting their potential in clinical settings.
Dementia and depression are the most prevalent neuropsychiatric disorders in geriatric populations, and their overlapping symptoms pose major challenges for differential diagnosis. In this study, we investigate open-weights Large Language Models (LLMs) for predicting dementia and depression severity from speech samples collected during standardized history taking interviews with 154 German-speaking subjects. We introduce an observer-based Global Depression Scale (GDS-D) aligned with the established Global Deterioration Scale (GDS), enabling parallel global staging of affective and cognitive symptoms. We compare three LLMs (Mistral 3.1, DeepHermes, Qwen3) in two settings: (1) zero-shot prediction and (2) LLM-based feature extraction for Support Vector Regression, using human and pause-enriched transcripts. Results show that LLMs effectively predict depression severity in zero-shot settings (best MAE of 0.60), while dementia assessment benefits substantially from structured feature extraction (best MAE of 0.78), reducing errors by up to 35% over zero-shot baselines. Pause-enriched transcripts achieve competitive performance with human transcriptions, demonstrating the viability of fully automatic screening pipelines for differential neuropsychiatric assessment.
